Anika Therapeutics, Inc. (ANIK)
21.42
+0.33
(+1.56%)
USD |
NASDAQ |
Oct 23, 16:00
21.42
0.00 (0.00%)
Pre-Market: 20:00
Anika Therapeutics Price to Book Value : 2.088 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.088 |
| October 22, 2026 | 2.056 |
| October 21, 2026 | 2.008 |
| October 20, 2026 | 1.993 |
| October 19, 2026 | 1.971 |
| October 16, 2026 | 1.948 |
| October 15, 2026 | 2.017 |
| October 14, 2026 | 1.974 |
| October 13, 2026 | 2.001 |
| October 12, 2026 | 1.996 |
| October 09, 2026 | 1.909 |
| October 08, 2026 | 1.875 |
| October 07, 2026 | 1.904 |
| October 06, 2026 | 1.864 |
| October 05, 2026 | 1.923 |
| October 02, 2026 | 1.862 |
| October 01, 2026 | 1.887 |
| September 30, 2026 | 1.917 |
| September 29, 2026 | 1.944 |
| September 28, 2026 | 2.016 |
| September 25, 2026 | 1.986 |
| September 24, 2026 | 1.972 |
| September 23, 2026 | 1.986 |
| September 22, 2026 | 2.036 |
| September 21, 2026 | 2.018 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.029 |
| September 17, 2026 | 2.050 |
| September 16, 2026 | 2.032 |
| September 15, 2026 | 2.038 |
| September 14, 2026 | 2.066 |
| September 11, 2026 | 2.034 |
| September 10, 2026 | 2.046 |
| September 09, 2026 | 2.036 |
| September 08, 2026 | 2.051 |
| September 04, 2026 | 2.029 |
| September 03, 2026 | 2.047 |
| September 02, 2026 | 2.101 |
| September 01, 2026 | 2.058 |
| August 31, 2026 | 2.034 |
| August 28, 2026 | 2.057 |
| August 27, 2026 | 2.032 |
| August 26, 2026 | 2.114 |
| August 25, 2026 | 2.086 |
| August 24, 2026 | 2.080 |
| August 21, 2026 | 2.123 |
| August 20, 2026 | 2.080 |
| August 19, 2026 | 2.072 |
| August 18, 2026 | 2.103 |
| August 17, 2026 | 2.093 |
| August 14, 2026 | 2.096 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Perspective Therapeutics, Inc. | 0.5671 |
| MiMedx Group, Inc. | 2.638 |
| ABVC BioPharma, Inc. | 2.605 |
| Intuitive Surgical, Inc. | 9.806 |
| Precigen, Inc. | 50.85 |
Price to Book Value Related Metrics
| PS Ratio | 2.500 |
| Price to Free Cash Flow | 536.80 |
| Price | 21.42 |
| Earnings Yield | -1.28% |
| Market Cap | 286.66M |